Commonly used reporting guidelines
| STROBE | Observational Studies |
| PRISMA | Systematic reviews of trials |
| PRISMA-P | Systematic review protocols |
| CONSORT | Randomised trials |
| SPIRIT | Randomised trial protocols |
| SRQR | Qualitative Research |
| CARE | Case Reports |
| STARD | Diagnostic studies |
| TRIPOD+AI | Prediction Models |
| ARRIVE | Animal Research |
| SQUIRE | Quality Improvement |
| CHEERS | Economic Evaluations |
| Search all |
Full bibliographic reference
Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF. Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich Plasma and Mesenchymal Stem Cells. J Bone Joint Surg Am. 2017;99(10):809-819.
Language
English
Reporting guideline website URL
Study design
Clinical trials, Experimental studies, Observational studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews
Clinical area
Rheumatology, Sport and exercise medicine, Surgery
Applies to the whole report or to individual sections of the report?
Ethical issues (consent etc.), Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.)
Additional information
Murray IR, Murray AD, Geeslin AG, Goudie EB, White TO, Petrigliano FA, LaPrade RF. Infographic: we need minimum reporting standards for biologics. Br J Sports Med. 2017. PMID: 28831016
Record last updated on
November 25, 2021